Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-12.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
The Adequacy of an Enteral Formula Feeding to Maintain Nutritional Status
Skip Navigation
Skip to contents

Ann Clin Nutr Metab : Annals of Clinical Nutrition and Metabolism

OPEN ACCESS

Articles

Page Path
HOME > J Clin Nutr > Volume 5(2); 2013 > Article
Original Article The Adequacy of an Enteral Formula Feeding to Maintain Nutritional Status
Kyoung Hwa Yoo, M.D., In Myung Oh, M.D., Ji Eun Park, M.D., Ju Sang Park, M.D., Eun Jeong Jang, M.D., Sang Jong Park, M.D., Sang Jung Kim, M.D., Sang Woon Park, M.D., Hyun Wook Baik, M.D., Ph.D.

단일 경장 영양액의 환자 영양상태 유지 및 개선 효과 적정성
유경화ㆍ오인명ㆍ박지은ㆍ박주상ㆍ장은정ㆍ박상종ㆍ김상중ㆍ박상운ㆍ백현욱
Journal of Clinical Nutrition 2013;5(2):76-81.
DOI: https://doi.org/10.15747/jcn.2013.5.2.76
Published online: August 31, 2013
Division of Gastroenterology, Department of Internal Medicine, DMC Bundang Jesaeng Hospital, Seongnam, Korea

분당제생병원 소화기내과
Received: 14 December 1901   • Revised: 14 December 1901   • Accepted: 14 December 1901
prev next
  • 5 Views
  • 0 Download
  • 0 Crossref
  • 0 Scopus
prev next

Purpose
It is a well-established fact that enteral nutrition is the preferred mode when compared with parenteral nu-trition for the purpose of recovery and maintaining nutri-tional status not only in surgical but also in chronic debili-tating patients. Further, this mode of nutrition is essential as it enhances preservation of gut mucosal integrity as well as immunity particularly in such patients. In a pro-spective multicenter clinical trial, we studied the effective-ness and safety of one specific enteral formula 'M'.Methods: We recruited 30 patients who were admitted to three hospitals (two university hospitals and one general hos-pital) in a metropolitan area for either surgery or treatment. The patients were given the enteral formula M at the dose of 25 kcal/kg/day for 7±2 days. Thereafter, we evaluated the performance and nutritional status of each patient by apply-ing subjective global assessment (SGA) scale, Karnofsky per-formance status scale, and stroke specific quality of life (SS-QOL) scale. We also measured the plasma markers spe-cific to nutritional status of such patients. In addition, we also recorded the consequent dose?response clinical symptoms such as diarrhea, abdominal pain, abdominal discomfort, bloating, nausea, and vomiting.Results: We found that the SGA scale score did not show significant change compared to the baseline score. However, both the Karnofsky performance status score and the SS-QOL score showed the tendency of improvement com-pared to the baseline score. We also found that there was a decrease in the serum markers used to signify the nutri-tional status of the patients, but this decrease was statisti-cally not significant when compared to the baseline score. Of the 30 patients enrolled for this study, 12 patients showed distinct clinical adverse symptoms. The most commonly ob-served adverse response was abdominal pain, although all other symptoms subsided spontaneously.Conclusion: We conclude that the administration of enteral formula 'M' to both perioperative and chronic debilitating pa-tients hardly elicited serious adverse response. In fact, the formula was significant in preserving the performance status and quality of life of both perioperative and chronic debilitat-ing patients. (JKSPEN 2013;5(2):76-81)


Ann Clin Nutr Metab : Journal of Clinical Nutrition
Close layer
TOP